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Since March 2020, the initial response from countries worldwide aimed to strengthen hospital-based care to prevent 
health systems collapse and death of infected patients of COVID-19. In June 2020, the World Health Organization declared 
that rehabilitation was the most disrupted healthcare service (World Health Organization, 2020). Yet, it has been declared by a 
consensus statement that rehabilitation is vital to recover from COVID-19 (Barker-Davies et al., 2020). The rehabilitation 
community has rightfully focused its current efforts on delivering pulmonary rehabilitation in acute, hospital or intensive care 
settings (Marta Lazzeri et al., 2020; Pedersini et al., 2020; Thomas et al., 2020). Long duration of hospital treatments can 
cause “post-intensive care syndrome” characterized by worsening physical disability and cognitive impairments due to 
immobilization, muscle wasting, and thoracic pain related to the use of a respirator (Thomas et al., 2020).  
We have not yet grasped the long-term impact of COVID-19 on rehabilitation needs. Previous evidence in other strains of 
severe acute respiratory syndrome (SARS) viruses shows that patients exhibit impaired lung and physical function and 
reduced quality of life years after an infection (BMJ Best Practice, 2021; Moldofsky & Patcai, 2011; Zhang et al., 2020). 
COVID-19 has a major impact on lungs, potentially resulting in severe bilateral pneumonia requiring intensive care (Huang et 
al., 2020). Rapidly expanding evidence shows that COVID-19 likely impacts multiple body systems (Chow et al., 2020; Oxley 
et al., 2020). A recent analysis of 143 participants in Italy found that 44% of patients report worsened quality of life two months 
after returning home from hospitalization (at least ten points on EuroQol-Visual Analog Scale [EQ-VAS]) (Carfì et al., 2020). 
Eighty-seven percent of patients reported persistence of at least one symptom including fatigue, dyspnea, or joint pain (Carfì 
et al., 2020). These results indicate potential long-term sequelae of COVID-19.   
ABSTRACT 
Purpose: Telerehabilitation could prevent sequelae from COVID-19. We aimed to assess the feasibility of telerehabilitation; 
describe pulmonary and functional profiles of COVID-19 patients; and explore the effect of telerehabilitation on improving 
pulmonary symptoms and quality of life. Methods: We conducted a pre-experimental, pre-post pilot study. We recruited 
COVID-19 patients who had returned home following hospitalization. The intervention included eight weeks of supervised 
physiotherapy sessions. We documented technological issues, success of recruitment strategies, and participants’ 
attendance to supervised sessions. We measured the impact of pulmonary symptoms on quality of life and functional health. 
Results: We scheduled 64 supervised sessions with seven participants with few technological issues. Initial scores showed 
that pulmonary symptoms moderately to highly impacted quality of life. At eight weeks, all patients had improved from 10 to 
45 points on the EuroQol-Visual Analog Scale (EQ-VAS) instrument, indicating clinical significance. Conclusion: We 
developed and administered a telerehabilitation intervention during a global pandemic that targets key symptoms of the 
relevant disease.  
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The rehabilitation community is exploring new models of care to prevent long-term sequelae from COVID-19. The 
Stanford Consensus Statement recommends individualized rehabilitation that focuses on relieving symptoms of dyspnea and 
improving physical function and quality of life (Barker-Davies et al., 2020). In addition, rehabilitation of COVID-19 should focus 
on education and development of self-management skills (Barker-Davies et al., 2020). The Centers for Disease Control and 
Prevention (CDC) framework for primary care following a pandemic advocate that rehabilitation should be a priority for patients 
recovering from an infection (Krist et al., 2020). To comply with the public health recommendation on social distancing, 
delivering rehabilitation remotely appears to be the most feasible option.  
Telerehabilitation is an ideal method of healthcare delivery in this context because it can provide safe, long-distance 
services; adhere to the sanitary measures required by the pandemic; and cover a large geographic region. Telerehabilitation 
also protects clinicians since patients may still be infectious for days following hospital discharge. Finally, pulmonary 
telerehabilitation was shown to be equivalent with in-person pulmonary rehabilitation (Marquis, Larivée, Dubois et al., 2014; 
Marquis, Larivée, Saey et al.., 2015; Tousignant et al., 2012; Vasilopoulou et al., 2017). In this paper, we identify gaps in 
providing telerehabilitation for COVID-19 patients after hospitalization. 
We aimed to (1) assess the feasibility of providing telerehabilitation for COVID-19 patients after hospitalization; (2) 
describe pulmonary and functional profiles of COVID-19 patients; and (3) describe the effect of the intervention on improving 
pulmonary symptoms and quality of life. 
METHODS 
ELIGIBILITY AND RECRUITMENT 
We aimed to design a safe virtual rehabilitation intervention that would help patients’ recovery following hospitalization for 
COVID-19. We would follow up to ten patients for this proof-of-concept study. We included participants who received a 
diagnosis of COVID-19 (confirmed by hospital health professional) and were hospitalized due to COVID-19 or stayed in 
intensive care. Eligible participants had returned to their place of residence post hospitalization. Participants also had access 
to a device that had a camera and could connect to the Internet, were considered medically stable by an attending physician to 
participate in our intervention, and were able to follow instructions remotely.  
As the study was ongoing, people in the community having COVID-19 started experiencing persistent symptoms which 
led to the term “Long-COVID.” Long-COVID is defined as the presence of signs and symptoms four weeks or longer after the 
infection of COVID-19 (National Institute for Health and Care Excellence, 2020). To help us understand community-based 
needs for patients who had COVID-19, one patient partner (participant seven) received our intervention. This participant 
signed a consent form and reported important symptoms and limited recovery but did not require hospitalization. Since her 
initial assessment did not differ from those of the other participants at the start of the intervention (see Table 3), we chose to 
include her results in our main analyses. 
Participants were recruited by physicians and physiotherapists working in two COVID-19 designated hospitals. Study 
recruiters ensured that patients were hospitalized for symptoms related to COVID-19, and not for a comorbidity accentuated 
by COVID-19. This research was approved by the Research Ethics Board of Centre intégré universitaire de santé et de 
services sociaux de l’Estrie – Centre hospitalier universitaire de Sherbrooke. A research professional explained consent forms 
to patients via telephone interviews and obtained written consent via email from all participants. We completed the consent 
process without an in-person meeting, following public health safety recommendations. 
DEVELOPMENT OF THE COVID-19 VIRTUAL REHABILITATION CLINIC 
Development of the COVIE-19 Virtual Rehabilitation Clinic began in April 2020. No data was available on the 
effectiveness of rehabilitation interventions in the community for patients with COVID-19. Based on discussion with intensive 
care physicians and physiotherapists and emerging international viewpoints and opinions (Barker-Davies et al., 2020), we 
hypothesized that the best evidence-based framework around which to design the intervention was pulmonary rehabilitation. 
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ADAPTING EVIDENCE-BASED PULMONARY REHABILITATION PROGRAMS TO 
COVID-19 
Although COVID-19 mainly affects the lungs (Barker-Davies et al., 2020), early observations showed that COVID-19 
patients have other significant deficits such as fatigue and muscle pain (Carfì et al., 2020). These symptoms are also common 
in patients with lung diseases such as chronic obstructive pulmonary disease.  
Pulmonary rehabilitation is a core non-pharmacological treatment for people with lung diseases (McCarthy et al., 2015) 
and is based on an exercise prescription for special populations (Garvey et al., 2016). Appendix A describes the key 
components of pulmonary rehabilitation and the components that we included in our program. We included breathing 
exercises, as these are often used during an exacerbation of pulmonary diseases to help correct alterations in respiratory 
patterns (Barker-Davies et al., 2020; Zadro et al., 2020). We included cardiovascular exercises in the form of mobilization-
related interventions (e.g., walking) and goal-directed practice (e.g. stair training) (Zadro et al., 2020). We included 
strengthening exercises of the upper and lower body by targeted resistance training (e.g., sit-to-stand) or by using material 
available in a participant’s home setting (e.g., weights, cans, bags of flour) (Zadro et al., 2020). We included multiple exercise 
components to address the multiple functional deficits of COVID-19. 
Patient education on self-management skills is also a requirement of pulmonary rehabilitation to integrate behavioral 
changes that will foster a return to physical activities and improve physical function (Bourbeau & Nault, 2007). Indeed, a 
patient often completes most of the exercise dosage of any outpatient rehabilitation through unsupervised sessions at home. 
We addressed patient education during the warm-up and cooldown periods of the supervised sessions. These periods also 
allowed the physiotherapist to ensure the patient safely returned to his/her baseline physiological state. 
We did not include content that addressed education on pulmonary medication, psychological counseling, or nutritional 
counseling from the pulmonary rehabilitation guidelines (Appendix A). Compared to diseases normally treated in pulmonary 
rehabilitation (e.g., COPD, pulmonary fibrosis), COVID-19 does not appear to be a chronic condition that requires long-term 
advice on nutrition or medication. However, future evidence may indicate a role for long-term advice. New evidence will also 
shed light on the psychological impact of having lived through COVID-19, and a new model may need to be developed to 
address interdisciplinary community-based rehabilitation. 
To ensure the safety of each of the participants, the physiotherapist had the telephone number to reach the participant as 
well as his/her physical address to send first responders if necessary as well as the telephone number of the participant's 
caregiver. When available, the caregiver was present to further ensure safety and the exercises were carried out in a safe 
place (near a wall or a chair for support if necessary). 
DELIVERING THE TELEREHABILITATION INTERVENTION 
Our telerehabilitation intervention is a physiotherapist-led intervention delivering a pulmonary telerehabilitation program in 
two stages for a suggested follow-up at eight weeks (Burge et al., 2020; Hansen et al., 2020; McCarthy et al., 2015; 
Vasilopoulou et al., 2017). The intervention was given by a physiotherapist who has experience with respiratory diseases and 
with the advice of a professor with 15 years of clinical experience in chronic respiratory diseases as well as research expertise 
in telerehabilitation for this population.  
PHASE ONE: INTENSIVE REHABILITATION AND EDUCATION 
We provided two weekly supervised sessions of breathing, cardiovascular, and strengthening exercises and intensive 
patient education on self-management skills (Bourbeau & Nault, 2007). Since COVID-19 may produce heterogeneous 
symptoms, our intervention was individualized according to the participant’s needs (Barker-Davies et al., 2020). We matched 
the dosage of the exercise to patient’s main goals and symptoms. For example, some participants needed more 
cardiovascular exercises because their dyspnea more significantly impacted their quality of life, while others might have 
required more strengthening exercises to counteract muscle weakness. The physiotherapist personalized each exercise to 
ensure optimal dosage and loading. Participants were advised to complete an additional 30-minute unsupervised 
cardiorespiratory and breathing exercise session daily and a one-hour unsupervised strengthening exercise session per week.  
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PHASE TWO: CONSOLIDATION  
We provided once-weekly supervised sessions for consolidation of self-management skills. Participants were advised to 
complete one-each additional 30-minute unsupervised cardiovascular and breathing exercise sessions daily and two one-hour 
unsupervised strengthening exercise sessions per week. By gradually decreasing the number of supervised sessions per 
week, we intended to develop the self-management skills necessary for patients to return safely to their usual activities. We 
continued phase one as long as the participant’s condition required a follow-up of two sessions per week until the participant 
was ready to move to phase two. Each participant could receive up to 16 one-hour supervised sessions over eight weeks. 
TECHNOLOGY 
The infrastructure includes a clinical management system focused on telerehabilitation with videoconferencing 
components (i.e., camera, speakers, microphone). The software environment consists of two interfaces that combine user-
friendly and optimal control of the technology to enhance the telerehabilitation experience for both the participant and the 
clinician. A web link is sent to the patient to activate the session. The software is a cloud-based multi-point, multi-view, and 
multi-stream (video and audio) telecommunication system. This technology is freely available upon request to the authors of 
this study. The platform used for the telerehabilitation sessions was built by the research team in previous work and the code 
is Open Source. 
FEASIBILITY OUTCOMES 
We documented four aspects of feasibility. First, although our team has developed and used the Tera+ platform in 
numerous telerehabilitation trials, tracking technological and server issues remains essential to offer telerehabilitation broadly. 
The physiotherapist delivering the intervention kept a logbook of all technological issues that happened during consultations 
throughout the project and worked with an engineer to resolve them in a timely matter. 
Second, one of the most complex issues facing community-based clinical research teams worldwide is the capacity to 
recruit participants during a global pandemic. During recruitment, the research team tracked the referrals of each professional 
to determine the most effective recruitment techniques and settings. We also considered the recruitment flow (i.e., number of 
potential participants received per week) and time required to reach the desired sample size of ten participants.  
Third, we documented adverse events during the intervention (falls or injuries) and we documented (self-reported by 
participants) what other symptoms the participants had (vertigo, loss of balance, loss of smell, dizziness). 
Finally, we measured the attendance rate by the number of sessions attended as per the originally scheduled date, and 
we tracked the number of absences. We documented the number of weeks for each of the two phases (intensive rehabilitation 
and education and consolidation). We measured satisfaction with our intervention with a questionnaire developed from the 
adaptation and translation of the Patient Satisfaction Questionnaire for Telemedicine (Yip et al., 2003). This questionnaire 
consists of 15 statements rated on a five-level Likert scale where one represents “strongly disagree” and five represent, 
“strongly agree.” Scores of 70 out of 75 represent high satisfaction. 
CLINICAL OUTCOMES TO CHARACTERIZE PULMONARY AND FUNCTIONAL 
PROFILES 
CORE OUTCOME SET 
No core outcome set exists to study the rehabilitation of COVID-19 patients. We needed easy-to-use measures that 
addressed domains relevant to assessing pulmonary symptoms and functional impacts on quality of life. 
Table 1 describes our three standardized tools to assess pulmonary symptoms, quality of life and physical activity levels. 
We administered the EuroQol-5D-5L (EQ-5D-5L) and EQ-Visual Analog Scale (VAS) to assess functional health and quality of 
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anxiety/depression. Each question is scored on a one-to-five-point scale, where one represents no impact on quality of life. 
The EQ-VAS is a scale from 0 to 100 where 0 represents the “worst imaginable health” and 100 the “best imaginable health”. 
In the context of COVID-19, the minimum clinically important difference (MCID) for the EQ-VAS is proposed as ten points 
(Carfì et al., 2020). 
Table 1 
Core Outcome Set to Assess Pulmonary and Quality of Life Domains of COVID-19 Patients 
Measure  Number of 
items  
Response format  Range of 
score  
Score interpretation  MCID  
COPD 
Assessment Test 
(Polkey et al., 2018)  
8  5-point Likert scale  0 – 40   <5: No impact  
<10: Low impact  
10 – 20: Medium impact  
20 – 30: High impact  
>30: Very high impact  
2 or more points 
(Kon et al., 2014)  
EQ-5D-5L 
(EQ-5D, 2020)  
5  5-point Likert scale 




0 – 5  Higher score = worst health  Not reported 
 
EQ-VAS 
(EQ-5D, 2020)  
1  100-point visual 
analog scale from 
“The best health you 
can imagine” to “the 
worst health you can 
imagine”  
0–100  Higher score = better health  EQ-VAS : 10 points 
(Carfì et al., 2020) 
 
 
We administered the COPD Assessment Test (CAT) to assess the severity of pulmonary symptoms and their impact on 
quality of life (Polkey et al., 2018). The CAT consists of eight questions and each question is scored from zero to five points for 
a maximum score of 40 points. Higher scores represent a decrease in quality of life due to pulmonary symptoms. A difference 
of two points is considered a clinically significant change (Kon et al., 2014). 
ADDITIONAL CLINICAL OUTCOMES 
We assessed four additional outcomes to describe pulmonary symptoms. We assessed physical activity levels using the 
Baecke Physical Activity Questionnaire (Pitta et al., 2006; Troosters et al., 2010). The questionnaire assesses three domains: 
occupational activities, sports activities, and recreational activities. Questions related to sports activities were adapted to the 
activities allowed during the lockdown (e.g., walking, yoga, home training, running). General physical activity is the summation 
of the score of the three domains. The score ranges from three to 15 points, with higher scores indicating higher physical 
activity participation.   
We evaluated cough categorized as strong or weak, productive or not, dry or wet, effective or not. A normal cough is 
considered to be strong, not productive, dry and effective. We assessed the sensation of dyspnea with the modified Borg scale 
(0–10). A high score indicates a higher sensation of shortness of breath whereby an improvement of one point is considered 
clinically significant (Ries, 2005). Finally, we assessed pulmonary secretions including frequency, intensity, quantity (number 
of times/day), appearance (thick or liquid) and color. We measured body pain using a 10-point visual analog scale. Higher 
scores indicate higher levels of body pain and a difference of two points is considered a MCID (Ries, 2005). 
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DATA COLLECTION AND ANALYSIS 
An independent research coordinator who did not deliver the intervention collected outcomes. At the end of each 
evaluation, the independent researcher gave the results to the physiotherapist in charge of the intervention to individualize the 
sessions according to the remaining deficiencies. The independent researcher collected all outcome measures online via the 
TeRA+ telerehabilitation platform. Data were collected twice: at the beginning of the intervention, and eight weeks later. We 
used frequency counts and descriptive statistics to analyze feasibility outcomes and pulmonary and functional profiles at 
baseline. To explore the impact of the intervention, we assessed whether each patient reached the MCID in outcomes 
between the beginning and end of the sessions.  
RESULTS 
PARTICIPANTS 
Of the ten participants we attempted to recruit, we were able to recruit seven participants. Only one participant did not 
complete the intervention since he required re-hospitalization. Characteristics of participants are described in Table 2. 
Participants were between 49 and 80 years of age and three of seven were women. Participants reported having high blood 
pressure (3/7 participants), hypercholesterolemia (3/7) and asthma (2/7). Participants’ body mass indices ranged from 
21 kg/m2 to 39 kg/m2.  
Table 2  
Characteristics of Participants 
















1 49 M HBP, HC 21.5 Yes 3 2 8 Yes 
2 56 F Asthma, HC, 
HT4 
32.4 No 1 2 4 No 
3 80 M DB, Asthma 28.6 Yes 1 N/A 2 Yes 
4 59 M N/A 30.9 No 5 3 13 Yes 
5 64 M HBP, HC 23.9 No 7 1 15 Yes 
6 53 F HBP, KD 39.3 Yes 8 0 16 Yes 
7 49 F N/A 27.0 No 1 4 6 No 




We identified four categories of technological issues during the intervention. (1) In 34% of sessions, we experienced lack 
of synchronization between audio and video caused by a slow Internet connection. (2) In 19% of sessions, notifications from 
other applications on mobile devices interrupted the session and required participants to reconnect to continue the session. (3) 
In three percent of sessions, participants could not connect because they either used an unsupported Internet browser for 
Tera+ (Tera+ is supported only by Google Chrome or Safari), they lost the Internet connection, or they experienced difficulty 
connecting to the platform. (4) Participants had issues activating their microphone and camera each time they connected to 
the platform. Some participants could solve issues by themselves while others required help from the physiotherapist. All the 
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RECRUITMENT PROCESS 
We centered our recruitment strategy on identifying all patients referred to our two COVID-19 designated hospitals within 
our administrative region. We identified one physician for each site and the physiotherapist’s team of Centre hospitalier 
universitaire de Sherbrooke. We found that they independently triaged patients to be recruited to our project. The 
physiotherapist team referred eleven participants and physicians did not send any candidates.  
For the recruitment flow, we received on average two or three candidates each week in the first month (May), and one 
additional participant in the first week of June. It took two months (early May to late June) to recruit seven participants. The 
number of new cases admitted to COVID-19-designated hospitals rapidly fell as our region implemented stringent public health 
safety measures. To increase our recruitment capacity, we aimed to offer our intervention to other administrative regions since 
the intervention was delivered remotely. However, we faced communication issues with these new COVID-19 hospitals, and 
limitations from the ethics approval process. For these reasons, we decided to close recruitment after two months. 
Two contacted participants refused to take part in the project and three did not have the necessary technology (i.e., 
computer with a camera, tablet, or smartphone). Our recruitment rate was 55% (6/11). The research team identified a patient 
partner (participant seven) to assess community-based rehabilitation needs, and we included this patient in our recruitment 
sample.  
ATTENDANCE AT SUPERVISED SESSIONS 
All participants attended the supervised sessions scheduled by the physiotherapist. We delivered 64 supervised sessions. 
The total number of supervised sessions per participant ranged from four to 16 with a median of eight. Participants postponed 
only two out of 64 sessions (attendance rate: 97%). The duration of the two phases for each participant and the number of 
supervised sessions are described in Table 2.  
SAFETY AND SATISFACTION 
No serious adverse events were reported during or after the sessions in this limited sample. Satisfaction scores ranged 
between 71 and 74 out of 75, representing high satisfaction for all participants.  
CLINICAL OUTCOMES 
PULMONARY AND FUNCTIONAL PROFILES 
Table 3 describes the pulmonary and functional profiles of the participants before the intervention. Initial CAT scores 
showed that pulmonary symptoms moderately impacted quality of life in five participants (scores between 10 to 20/40). One 
participant was highly impacted (21/24) and one experienced a very high impact on quality of life (38/40). The EQ-VAS ranged 
between 25 and 70 points with a median of 50 points. The dimensions of EQ-5D-5L were heterogeneously impacted. The 
range of scores for self-care was one to five. For usual activities, this metric ranged from three to five; for mobility it ranged 
from one to four; for pain/discomforts it ranged from one to four; and for anxiety/depression from one to three. Five participants 
had a low level of physical activity (score <7.5) before the intervention, and two had a satisfactory level (score ≥9). Appendix B 
describes levels of physical activity for the three dimensions (occupational activities, sports activities and recreational 
activities). 
Four participants had pain located in the neck or shoulder because of COVID-19. One participant had pain in the leg 
caused by a nerve compression that occurred during an intensive care stay. Two participants had a wet cough; one participant 
had a weak cough; and five participants had a strong, dry and effective cough. Six participants had a cough triggered by 
exercise. Two participants had thick and green secretions suggesting an infection. One participant was unable to expectorate, 
and one participant had liquid and white secretions. Three participants didn’t have any secretion. One participant had dyspnea 
they ranked between six and eight out of ten (Borg scale) indicating difficulty in breathing during exercise. 
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Pulmonary and Functional Profiles before the Intervention 





Pain Pulmonary symptoms 




depression At rest 
On 
Exertion Cough Secretion BORG 
1 11 70 2 1 3 1 1 6.0  0 0 NTR * None 7 
2 38 30 3 3 3 2 3 9.1  5 8 Wet * Thick, green 8 
3 21 60 3 5 5 1 3 4.9  0 0 NTR * Thick, green 8 
4 14 60 4 4 5 4 3 7.0  0 0 NTR * None 7 
5 10 50 3 2 3 4 1 6.9  0 2 NTR Liquid, white 8 




7 18 40 1 2 3 2 1 9.8  4 8 Wet * None 7 
min. – max. 10–38 25–70 1–4 1–5 3–5 1–4 1–3 6.0–9.8 0–5 0–8 N/A N/A 6–8 
Note. CAT: COPD Assessment Test; For the physical activity: <7.5 represented Low levels of physical activity / [7.5–9.0 [: Moderate level / ≥9: Satisfactory level; NTR: Nothing to 
report, the cough is strong, effective and dry; *exercise induced cough 
 
Table 4 describes the pre-post changes for our main outcomes for each participant. For the EQ-VAS scores, the range of improvement was between 10 and 45 points, reaching 
the MCID (10 points). For the CAT score, five out of six participants improved from six to 13 points out of 40, reaching MCID (two points). At the end of the intervention, two 
participants had no impact of pulmonary symptoms on their quality of life (CAT score <5/40), two participants had a low impact (CAT score between 5 and 10/40), one participant 
had a moderate impact (CAT score 17/40) and one participant still had a high impact (CAT score 25/40). At the end of the intervention, two participants increased their score on the 
Baecke Physical Activity Questionnaire passing from a low level of physical activity to a moderate level. Two participants increased their scores by 0.2 and 1.0 points but were still 
considered at a low level of physical activity. The two participants maintained their satisfactory level through the end of interventions. Appendix B includes the preliminary impact of 
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Table 4  
Preliminary Impact of the Intervention on Core Outcomes Measures 
  CAT  EQ-VAS  
Participant  Baseline 8 weeks Delta  Baseline  8 weeks Delta  
1 11  3  8 * 70  80  10 * 
2 38  25  13 * 30  65  35 * 
3 21  -  -  60  -  -  
4 14  8  6 * 60  80  20 * 
5 10  4  6 * 50  95  45 * 
6 16  6  10 * 25  40  15 * 
7 18  17  1  40  70  30 * 
min. – max. 10 – 38 3 – 25 1 – 13 25 – 70 40 – 95 10 – 45 
Note. CAT: COPD Assessment Test; Delta: absolute; *: Achieve the MCID 
Color code for CAT scores 
 No impact 
 Low impact 
 Moderate impact 
 High impact 




We developed and safely delivered a fully online telerehabilitation intervention for patients returning home after a hospital 
stay for COVID-19. We adapted an evidence-based pulmonary telerehabilitation intervention to design this telerehabilitation 
intervention (Barker-Davies et al., 2020; Burge et al., 2020; Hansen et al., 2020; Vasilopoulou et al., 2017). This study helped 
us identify three important research gaps for future research. 
RECRUITMENT PROCEDURE 
Our recruitment strategy was centered on recruiting patients from COVID-19-designated hospitals and was designed to 
meet the need for community-based rehabilitation. We worked in close collaboration with physicians and physiotherapists in 
COVID-19 -designated hospitals. They identified the participants who were medically stable, able to follow instructions 
remotely, and safely participate in rehabilitation remotely. While ensuring safety, this strategy significantly limited recruitment. 
New cases rapidly declined in our administrative region and delays in ethics clearances occurred during summer to recruit 
patients from other hospitals and regions. 
Moreover, limiting recruitment to hospitals was not optimal given current knowledge of COVID-19 patient profiles. Current 
evidence proposes four COVID-19 severity patterns: (1) Asymptomatic infected patients; (2) Symptomatic patients isolating at 
home; (3) Symptomatic patients admitted to a hospital and (4) Symptomatic patients requiring ventilatory support in critical 
care (Barker-Davies et al., 2020). Our strategy for the intervention only met the needs of patients in the last two groups. As 
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new rehabilitation paradigms are emerging for the first two groups, they may also require pulmonary rehabilitation using a 
similar model to ours (Carfì et al., 2020; Greenhalgh et al., 2020).  
Future studies should assess telerehabilitation for all symptomatic adults with persistent symptoms and delayed recovery 
(i.e., three weeks after infection) (Greenhalgh et al., 2020). There should be multiple recruitment channels focused on 
answering community-based needs. Telerehabilitation is adapted to the context of the pandemic and can deliver care remotely 
to almost any geographical region. 
FEASIBILITY RESULTS  
Although technological issues with the Tera+ platform did not prevent sessions from happening, our records of 
technological issues indicate that healthcare professionals may need training before using the platform, as well as access to 
an efficient online support service. Technological issues did not appear to impact participants’ satisfaction. All participants 
attended the scheduled supervised sessions, suggesting that participants perceived the intervention as very useful to their 
health. Participants received a median of eight supervised sessions by a physiotherapist over eight weeks. At the end of the 
intervention, participants were asked whether they would need further rehabilitation services after the eight weeks of our 
intervention. Five participants stated that eight weeks of rehabilitation was adequate; one would have preferred a longer 
follow-up. In future studies, patients requiring additional rehabilitation beyond eight weeks should be offered to continue 
rehabilitation outside of the research project. 
PULMONARY AND FUNCTIONAL PROFILES OF COVID-19 PATIENTS 
We found that COVID-19 patients still faced moderate to severe pulmonary and functional disabilities when returning 
home after hospitalization. Clinical profiles of the participants were heterogeneous since some participants required several 
weeks in intensive care while others required only a short hospital stay. These differences may explain the wide range of 
disabilities across domains among our participants at the beginning of the intervention, but other factors may also explain 
these differences (e.g., pre-existing comorbidities, age, etc.). Participants who required an intensive care stay might have 
exhibited greater impairment of pulmonary symptoms (dyspnea on exertion). Within this intervention, some participants will 
remain in phase one longer, while others may move to the consolidation phase and the end of rehabilitation faster.   
Our preliminary clinical results suggest that telerehabilitation may help participants recover from COVID-19. All of our 
participants increased their quality of life scores by at least 10 points. In contrast, recent evidence suggests that close to half of 
COVID-19 patients will experience a decrease of ten points in their quality of life after eight weeks without interventions (Carfì 
et al., 2020). 
LIMITATIONS 
Our intervention is adapted from evidence-based pulmonary telerehabilitation, but we excluded components that may be 
required to achieve interdisciplinary community-based care as we learn more about long-term rehabilitation needs of COVID-
19 patients. Our recruitment strategy was limited by the unique COVID-19 context because clinical teams within designated 
hospitals faced staff shortages and rapid turnover. Also, clinical settings faced daily to weekly changes in procedures due to 
frequently changing recommendations from government officials. Despite this context, we could build communication channels 
with attending physicians and physiotherapists and understand the environments of COVID-19 units. The results of this study 
are not generalizable to all patients recovering from COVID-19. Several COVID-19 rehabilitation subgroups likely exist. The 
lack of a control group and the small sample size precludes a precise assessment of the effectiveness of the intervention 
versus natural recovery. Another limitation of this study is that COVID-19 is a novel virus and there was no validated tool for 
this population when this study took place.  
There was no serious adverse event in this study, but our sample size was small and new emerging evidence requires 
intensive effort to better recognize a wide array of post-COVID symptoms that patients may experience in the months following 
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each exercise component to better describe exercise tolerance and intolerance in this population during the short-term 
rehabilitation period following a hospitalization. 
CONCLUSION 
We developed and safely delivered a fully online telerehabilitation intervention for patients returning home after being 
hospitalized for COVID-19. We observed that patients recovering from COVID-19 showed heterogeneous pulmonary and 
functional profiles, and our participants experienced moderate to severe symptoms. Preliminary results showed that eight 
weeks of supervised physiotherapy sessions may improve symptoms, quality of life, and return to physical activities in COVID-
19 patients.   
KEY MESSAGES 
What is already known on this topic: 
1. Evidence shows that COVID-19 likely impacts multiple body systems and can expose potential long-term sequelae.  
2. Initial response from countries worldwide aimed to strengthen hospital-based care to prevent health systems’ 
collapse and death of infected patients. 
3. The ideal solution for COVID-19 would be to deliver rehabilitation remotely using technology to provide safe, 
physically distanced care. 
What this study adds 
1. We developed and safely delivered a fully online telerehabilitation intervention for patients returning home after being 
hospitalized for COVID-19. 
2. We centered our recruitment procedure on COVID-19-designated hospitals and likely missed many patients in the 
community who may require rehabilitation to recover from COVID-19 although they did not require hospitalization.  
3. We found that some patients recovering from COVID-19 exhibited moderate to high levels of pulmonary and 
functional disability. 
4. Preliminary results showed that eight weeks of supervised physiotherapy sessions may improve pulmonary 
symptoms and quality of life in COVID-19 patients. 
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APPENDIX A  
Components of the Telerehabilitation Intervention (Burge et al., 2020; Garvey et al., 2016; Hansen et al., 2020; McCarthy et 
al., 2015).  




Specific techniques to better control breathing 
and avoid feeling out of breath 
 






• Intensity should be between 50 and 
70% of the heart rate reserve (Jones et al., 
2015) 
• 150 minutes of cardiorespiratory 
activity per week 
 
Strengthen 
















Psychological counseling Stress management to prevent depression or decrease anxiety  
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APPENDIX B  
Supplemental Data 
  EQ-5D-5L  
  MOBILITY  SELF-CARE  USUAL ACTIVITIES  PAIN/ DISCOMFORT  ANXIETY/ DEPRESSION  
Participant  Baseline  8 weeks Baseline  8 weeks Baseline  8 weeks Baseline  8 weeks Baseline  8 weeks 
1  2  1  1  1  3  2  1  1  1  1  
2  3  1  3  1  3  2  3  3  3  1  
3  3  -  5  -  5  -  1  -  3  -  
4  4  3  4  1  5  3  4  1  3  2  
5  3  2  2  1  3  2  4  2  1  1  
6  3  3  2  1  4  3  4  3  2  2  
7  1  1  2  1  3  3  2  3  1  2  
min. – max. 1 – 4   1 – 3   1 – 5  1 – 1   3 – 5  2 – 3   1 – 4   1 – 3    1 – 3   1 – 2   
 
  PAIN  
  AT REST  ON EXERTION  
Participant  Baseline  8 weeks Delta  Baseline  8 weeks Delta  
1  0  0  0  0  0  0  
2  5  2  3  8  4  4  
3  0  -  -  0  -  -  
4  0  0  0  0  0  0  
5  0  0  0  2  0  2  
6  0  0  0  4  0  4  
7  4  2  2  8  1  7  
min. – max. 0 – 5   0 – 2   0 – 2   0 – 8   0 – 4   2 – 7   
Note. Delta: absolute 
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  BAECKE PHYSICAL ACTIVITY QUESTIONNAIRE 
  OCCUPATIONAL ACTIVITIES  SPORTS ACTIVITIES  RECREATIONAL ACTIVITIES  
Participant  Baseline  8 weeks Level of 
physical activity 
at T2 
Baseline  8 weeks Level of 
physical activity 
at T2 
Baseline  8 weeks Level of 
physical activity 
at T2  
1  2.3  2.5  Moderate 1.5  1.8  Low 2.3  2.8  Satisfactory 
2  3.1  3.8  High 2.3  2.3  Low 3.8  3.8  Satisfactory 
3  2.1  -  - 1.3  -  - 1.5  -  - 
4  2.8  2.9  Moderate 2.5  2.8  Satisfactory 1.8  2.5  Satisfactory 
5  2.4  2.5  Moderate 2.3  2.0  Low 2.3  3.0  Satisfactory 
6  2.1  2.4  Low 2.0  2.0  Low 2.3  2.3  Low 
7  3.0  3.5  High 3.0  2.5  Satisfactory 3.8  3.8  Satisfactory 
min. – max. 2.1–3.8   2.4–3.8   N/A 1.3–3.0   1.8–2.8   N/A 1.5–3.8   2.3–3.8   N/A 
Note. Occupational activities: <2.5: low level; [2.5–3.1]: moderate level; >3.1: high-level; Sport and recreational activities: <2.5: low level; ≥2.5: satisfactory level 
 
  PULMONARY SYMPTOM  
  COUGH  SECRETIONS  MODIFIED BORG SCALE  
Participant  Baseline  8 weeks Baseline  8 weeks Baseline  8 weeks Delta  
1  NTR * NTR None  None  7  2  5  
2  Wet * Greasy  Thick, green  Thick, yellow  8  7  1  
3  NTR * - Thick, green  -  8  -  -  
4  NTR * NTR None   None  7  4  3  
5  NTR   NTR Liquid, white  None  8  4  4  
6  Weak, non-effective * NTR Can’t expectore   None  6  4  2  
7  Greasy * NTR * None  None  7  4  3  
min. – max. N/A  N/A  N/A  N/A  6 – 8   2 – 7   1 – 5   
Note. NTR: Nothing to report, the cough is strong, effective and dry; *exercise induced cough 
